BSECompany UpdateMgmt Change4 Nov 2026
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSEResultResults4 Nov 2026
Filtron Engineers Ltd
Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026
Filtron Engineers Ltd has announced its standalone and consolidated financial results for the quarter and half year ended September 30, 2026, showing a profit of ₹22,871.80 lakhs and ₹22,972.51 lakhs respectively. The company has also approved the execution of a rent agreement for its registered office.
BSEBoard MeetingResults4 Nov 2026
Sunil Agro Foods Ltd-$
Sunil Agro Foods Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Un-Audited Financial results for the second quarter and half year ended September 30, 2026.
Sunil Agro Foods Ltd has scheduled a Board Meeting on 12/11/2026 to consider and approve the Un-Audited Financial results for the second quarter and half year ended September 30, 2026.
BSECompany Update▲ PositiveResults4 Nov 2026
Krishival Foods Ltd
Media Release
Krishival Foods Ltd reported strong Q2 FY27 performance with consolidated EBITDA growing 64% YoY and EBITDA margin expanding to 16%. Revenue from operations increased 28% YoY to ₹85.66 crore and H1 revenue grew 50% YoY to ₹174.62 crore.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma has informed about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change4 Nov 2026
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateResults4 Nov 2026
Max Estates Ltd
Please refer the enclosed Investor Presentation.
Max Estates Ltd has released an investor presentation for Q2 FY27, highlighting its operating performance, portfolio growth, and strategic partnership with New York Life.
BSECompany UpdateResults4 Nov 2026
SBI Life Insurance Company Ltd
Please find attached Intimation under Regulation 30 and 47 of SEBI (LODR) Regulations, 2015.
SBI Life Insurance Company Ltd has announced the completion of dispatch of Postal Ballot notice on November 03, 2026, and the notice has been published in the print and electronic editions of the 'Financial Express' and 'Loksatta' on November 04, 2026.
BSECompany UpdateResults4 Nov 2026
Centum Electronics Ltd
Pls refer enclosed Earnings Presentation for Q2 / H1 FY 27.
Centum Electronics Ltd has released its Q2/H1 FY 27 earnings presentation, highlighting its position as a trusted partner for defence and strategic electronics, with a strong presence in high-reliability electronics manufacturing.
BSECompany Update▲ PositiveOrder Win4 Nov 2026
Max Estates Ltd
Please refer the enclosed Press Release.
Max Estates Ltd has announced pre-sales of ~INR 3,200 Crore in H1 FY27, with 2,100 Crore pre-sales in Q2 FY27, and a GDV pipeline balance of over INR 29,000 Crore to support future growth.
BSECompany Update▲ PositiveResults4 Nov 2026
Entero Healthcare Solutions Ltd
Investor Presentation on Unaudited Financial Results for the quarter and half year ended September 30, 2026
Entero Healthcare Solutions Ltd has released its unaudited financial results for Q2 and H1 FY27, showing strong organic growth, improved EBITDA margin, and positive ROCE and ROE.
BSEAGM/EGMM&A4 Nov 2026
Bharti Airtel Ltd
Notice of Postal Ballot by way of remote e-voting only.
Bharti Airtel Ltd has announced a postal ballot notice for approval of Employee Stock Option Scheme 2026 through Bharti Airtel Employees' Welfare Trust. The scheme aims to provide stock options to employees of the company and its unlisted subsidiary companies.
BSECompany UpdateInsolvency4 Nov 2026
Radhagobind Commercial Ltd
Outcome of COC meeting held on 04-11-2026
Radhagobind Commercial Ltd has announced the outcome of the 12th meeting of the Committee of Creditors (CoC) under the Corporate Insolvency Resolution Process (CIRP). The meeting was held on November 4, 2026, and the CoC approved various agenda items, including the voting procedure for Resolution Plans, the setting up of a Monitoring Committee, and the determination of the Resolution Professional's incentive.
BSECompany UpdateResults4 Nov 2026
Shivalik Bimetal Controls Ltd
Recording of earnings call of Q2 FY27
Shivalik Bimetal Controls Ltd has uploaded the audio recording of its Q2 FY27 earnings call on its website.